BR
Healthcare & Life Sciences

Braveheart

San Francisco, United Statesbraveheart.bio

Braveheart is a Healthcare & Life Sciences startup based in San Francisco, the United States, 1 tracked investor.

Active
2024
Founded
1
Investors

About Braveheart

Braveheart is a company founded in 2024 headquartered in San Francisco, the United States. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Braveheart is developing BHB-1893, a selective small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy, a rare heart muscle disease, through global late-stage clinical development.

Explore Braveheart's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States